At GoBroad Medical Institute of Hematology (Shanghai Center), we are dedicated to redefining outcomes for patients battling complex blood disorders through advanced BMT treatment (bone marrow transplantation). As a certified center for hematopoietic stem cell transplantation in China, our facility integrates advanced technology, multidisciplinary expertise, and patient-centered care to address conditions like refractory leukemia, multiple myeloma, and severe aplastic anemia. Led by Professor Wang Chun, a pioneer with over 30 years of experience in hematology, our team combines innovation with compassion, ensuring each patient receives tailored therapies that prioritize safety, efficacy, and long-term recovery. With 32 specialized laminar airflow transplantation rooms and a 300-bed capacity, we stand as a beacon of hope for those seeking world-class BMT treatment in Asia.

Precision and Expertise in BMT Treatment for Challenging Cases

BMT treatment is not a one-size-fits-all solution—it demands meticulous planning and execution. At GoBroad, we specialize in salvaging complex cases, including relapsed leukemia and elderly patients who are often deemed high-risk. Professor Wang Chun’s expertise in BMT treatment for refractory leukemia, particularly in older adults, has positioned our center as a leader in overcoming age-related challenges. Our protocols incorporate dual transplantation strategies, such as autologous followed by allogeneic transplants for multiple myeloma, to maximize remission rates. Advanced diagnostics, including genetic testing, flow cytometry, and fluorescence in situ hybridization (FISH), enable us to identify optimal donors and tailor conditioning regimens. For patients with T-cell lymphoma or myelodysplastic syndromes, we integrate BMT treatment with post-transplant immunotherapy, reducing relapse risks and enhancing immune recovery.

Innovative Support Systems for Safer Transplants

The success of BMT treatment hinges on robust infrastructure and relentless support. Our 32 laminar airflow rooms provide sterile environments critical for patients with compromised immunity during transplantation. Beyond physical facilities, our multidisciplinary team—hematologists, infection control specialists, and rehabilitation experts—collaborates to manage complications like graft-versus-host disease (GVHD) or infections. For instance, personalized immunosuppressive therapies are designed to balance graft acceptance and immune function. We also leverage specialized laboratory services, such as PCR testing and cellular morphology analysis, to monitor minimal residual disease (MRD) post-transplant. This real-time data allows dynamic adjustments to therapies, ensuring patients remain on track toward recovery. Additionally, our focus on elderly leukemia includes modified conditioning regimens that reduce toxicity without compromising efficacy, making BMT treatment accessible to older adults who might otherwise lack options.

Global Access and Integrated Care for International Patients

At GoBroad, we believe geographical boundaries should not limit access to life-saving BMT treatment. Our Shanghai Center offers seamless support for international patients, including real-time national insurance settlements and direct billing for commercial health policies. From visa assistance to post-transplant follow-up, our International Patient Service Center streamlines every step. For example, a patient with relapsed lymphoma can undergo CAR-T therapy followed by consolidative BMT treatment, all coordinated through a single point of contact. We also provide multilingual care teams and culturally sensitive support, ensuring comfort throughout the journey. Collaborations with institutions like the Shanghai Ruijin Hospital Blood Disease Medical Association further enhance our capacity to adopt global best practices, while our certified status guarantees adherence to the highest standards in BMT treatment.

Conclusion
Choosing GoBroad Medical Institute of Hematology (Shanghai Center) means entrusting your care to a team that views BMT treatment as both a science and an art. From pioneering dual transplantation strategies to prioritizing elderly patient needs and offering global accessibility, we blend innovation with unwavering compassion. Whether facing refractory leukemia, multiple myeloma, or severe aplastic anemia, our expertise in BMT treatment—rooted in Professor Wang Chun’s legacy and advanced infrastructure—delivers hope where it’s needed most. Discover how GoBroad changes complex challenges into stories of resilience, one transplant at a time. Here, healing begins with precision, expertise, and a commitment to putting patients first.